Advertisement

Pharmaceutisch Weekblad

, Volume 7, Issue 2, pp 42–45 | Cite as

Industry-University co-operation

Experiences, possibilities and problems as seen from a Swedish perspective
  • S. Agurell
Article
  • 30 Downloads

Abstract

The co-operation between industry and academia in Sweden has been subject to changing views in the society. The experiences of Astra Läkemedel AB are described and placed in a more general perspective. The co-operation in drug development includes the testing of biological hypotheses, drug formulation, preclinical and clinical studies,etc. An interesting way of collaboration is the position of ‘adjunct professor’. Some problems and concerns relating to these kinds of co-operation are discussed. It is concluded that co-operation is very useful, provided that one is aware of possible pitfalls.

Keywords

Public Health Internal Medicine Clinical Study Drug Development Drug Formulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Bohn, Scheltema & Holkema 1985

Authors and Affiliations

  • S. Agurell
    • 1
  1. 1.Astra Läkemedel ABSödertäljeSweden

Personalised recommendations